Today we’re a 1,700-strong team, delivering complex clinical care and medication services to over 200,000 diverse patients across the UK and Europe. Together, we’re dedicated to helping each and every patient make the most of their medicine, wherever they are.
So, using unparalleled insights, cutting-edge research and intuitive technology, we connect with people powerfully and personally, focusing on their unique needs, empowering them to achieve their goals, and supporting them every step of the way.
So, using unparalleled insights, cutting-edge research and intuitive technology, we connect with people powerfully and personally, focusing on their unique needs, empowering them to achieve their goals, and supporting them every step of the way.
Location: United Kingdom, England, Burton-on-Trent
Employees: 1001-5000
Phone: +44 333 103 9499
Founded date: 1992
Investors 1
| Date | Name | Website |
| 15.07.2021 | Vitruvian ... | vitruvianp... |
Mentions in press and media 8
| Date | Title | Description |
| 19.03.2026 | Sciensus Strengthens Leadership Team with Appointment of Annabelle Newman as General Counsel & Group Company Secretary | I'm proud to join Sciensus, which has a compelling mission to improve patients' lives by enabling access to medicines and specialist services.” — Annabelle Newman, General Counsel & Group Company SecretaryLONDON, UNITED KINGDOM, March 1... |
| 26.02.2026 | New European Survey of Rare Disease Patients Exposes Access Gaps and Urgent Need to Redesign Care Pathways | Listening to patients: Sciensus and Rare Patient Voice share new insights that reveal critical opportunity to improve care pathways When nearly half of respondents describe travel as a meaningful burden, it signals a clear opportunity for c... |
| 09.01.2026 | Sciensus names Julie Gosper as Managing Director, Rare & Specialty, to accelerate biopharma access to European markets | Expanded leadership bolsters Sciensus' end-to-end model for commercialisation of orphan and specialty medicinal products across complex European markets Sciensus has built a unique model that connects clinical expertise and digital capabili... |
| 22.10.2025 | Sciensus Expands and Enhances Cancer Services with Appointment of Dr Sherif Raouf as Clinical Director of Cancer | Dr. Raouf joins Sciensus to advance our mission to integrate clinical excellence with digital innovation in community cancer care We are excited to welcome Sherif to Sciensus to advance our mission to integrate clinical excellence with digi... |
| 10.03.2025 | Key Strategies for Successful Orphan Drug Launch in Europe, Upcoming Webinar Hosted by Xtalks | www.sciensus.com In this free webinar, learn about the importance of early patient engagement in shaping access strategies. Attendees will gain insights into key market access, pricing and reimbursement challenges in Europe. The featured sp... |
| 12.09.2024 | Sciensus dehnt das gesamte Spektrum seiner Dienstleistungen in Europa fortlaufend aus | Tina Lupberger ZUG, SWITZERLAND, September 12, 2024 /EINPresswire.com/ -- Sciensus, ein Globales Unternehmen im Bereich der Life Scienses, das sich auf den Zugang zu spezifischen Medikamenten, auf die Behandlungsunterstützung im Home Care B... |
| 13.08.2024 | Sciensus continues to extend the full range of its services across Europe | Tina Lupberger I look forward to working with our global team to drive and deliver digital+ solutions with an all-important human touch, and providing access to medicines for our patients in the EU and beyond.” — Tina Lupberger, Managing Di... |
| 01.08.2024 | Leading British nurse awarded top US healthcare honour | Prof Sir Jonathan Asbridge Prof Sir Jonathan Asbridge selected as Fellow of American Academy of Nursing I am honoured to have been recognised by the American Academy of Nursing. I look forward to actively participating in the organisation a... |